[go: up one dir, main page]

WO2014163262A1 - Composition pour traiter ou prévenir l'obésité, contenant de l'extrait de graines de piment - Google Patents

Composition pour traiter ou prévenir l'obésité, contenant de l'extrait de graines de piment Download PDF

Info

Publication number
WO2014163262A1
WO2014163262A1 PCT/KR2013/008809 KR2013008809W WO2014163262A1 WO 2014163262 A1 WO2014163262 A1 WO 2014163262A1 KR 2013008809 W KR2013008809 W KR 2013008809W WO 2014163262 A1 WO2014163262 A1 WO 2014163262A1
Authority
WO
WIPO (PCT)
Prior art keywords
seed extract
pepper seed
red pepper
extract
obesity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2013/008809
Other languages
English (en)
Korean (ko)
Inventor
김현아
김민숙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Industry Academic Cooperation Foundation of Mokpo National University
Original Assignee
Industry Academic Cooperation Foundation of Mokpo National University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Industry Academic Cooperation Foundation of Mokpo National University filed Critical Industry Academic Cooperation Foundation of Mokpo National University
Publication of WO2014163262A1 publication Critical patent/WO2014163262A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Definitions

  • the present invention relates to a composition for treating or preventing obesity, which comprises red pepper seed extract as an active ingredient.
  • the localization refers to a process in which fat cells are differentiated from progenitor cells to accumulate fat, and localization is known to cause metabolic diseases such as obesity, diabetes, fatty liver, and coronary heart disease.
  • the fat cells not only act as energy stores but also secrete protein hormones called adipocytokine as endocrine organs to perform various functions for maintaining energy homeostasis in the body.
  • adipocytokine protein hormones
  • Transcription factors that induce differentiation of adipocytes include adipocyte determination and differentiation dependent factor 1 / sterol response element binding protein 1c (ADD1 / SREBP1c), peroxisome proliferator activated receptor ⁇ (PPAR ⁇ ), and C / EBP (CCAAT). enhancer binding protein) has been reported.
  • the transcription factors are induced at different times during the adipocyte differentiation process, and interact with each other to regulate the expression of adipocyte specific genes and gradually induce the activation of adipocyte metabolism and adipocyte differentiation.
  • peroxisome proliferator activated receptor ⁇ belongs to nuclear receptors and induces the expression of many other genes as well as aP2, a fat cell-specific fatty acid binding protein.
  • PPAR ⁇ peroxisome proliferator activated receptor ⁇
  • adipocytes induced by the transcription factors proceeds to confluence, hormonal induction, clonal expansion, growth arrest and terminal differentiation.
  • growth arrest occurs when the cell cycle is G0 / G1.
  • the cell enters the clonal expansion stage in which one or two cell divisions are caused by appropriate differentiation stimulation and expression of C / EB ⁇ and C / EBP.
  • PPAR ⁇ and C / EBPa pro-adipocytes enter the phase of growth arrest, just before the stage of complete differentiation.
  • the final stage, terminal differentiation takes days to weeks, and mature growth cells are characterized by continuous growth arrest.
  • progenitor cells which were similar to fibroblasts at the beginning of differentiation, form morphological rounding-up, mRNAs such as lipoprotein lipase begin to be expressed, and transients of the transcription factors C / EBP ⁇ and C / EBP ⁇ . induction occurs. Then, PPAR ⁇ and C / EBPa are expressed to regulate or activate most of the genes that actually determine the phenotype of adipocytes. Through this process, lipid droplets appear in the cytoplasm and grow and merge over time to form one or several large droplets.
  • the obesity may be a problem with metabolic syndrome such as diabetes, obesity caused by the metabolic syndrome or metabolic syndrome may be caused by obesity.
  • Diabetes and related insulin resistance may also occur when blood glucose levels are within normal glucose tolerance during the development of type 2 diabetes. Insulin resistance is also affected by free fatty acids in the blood.
  • the free fatty acid is produced during the lipolysis process in which intracellular triglycerides are hydrolyzed to free fatty acids and glycerol and secreted from the adipocytes. Inflow of large amounts of free fatty acids from the intraperitoneal fat with high lipolytic activity into the liver lowers glucose utilization in the liver and interferes with insulin binding and action. As a result, the hepatic insulin elimination rate drops, resulting in higher insulin concentrations in the peripheral. Free fatty acids also reduce glucose utilization in the periphery of fat, muscle, etc., leading to increased insulin resistance.
  • Obesity treatment mechanisms to relieve metabolic syndrome such as obesity or diabetes and maintain proper weight include control of appetite, obstruction of digestion and absorption of fat, increase of energy consumption, and regulation of lipid metabolism. It has been reported that there are significant side effects.
  • Red pepper is one of the high temperature crops originated in South America, and it was introduced to Korea before and after Imjin War and used for food. Fruits are cone-shaped berries with little moisture, red ripe fruits can be dried and used as spices, ornamental, medicinal, etc., and leaves can be used as herbs.
  • the main ingredients contained in the flesh of the red pepper are capsanthin, capaorubin, vitamins, capsaicin and organic acids including capsaicin, which are spicy flavors.
  • the component is a capsaicinoid.
  • the main components of the spicy taste of the capsaicinoid including the capsaicin and its analogs are capsaicin and dihydrocapsaicin among the five homologues of the capsaicin.
  • the capsaicinoid content of red pepper powder which is made of varieties that are not spicy depending on the degree of spicy pepper, averages about 10 mg%, but the capsai of red pepper powder made of cheongyang pepper, known as spicy pepper, is on average.
  • the content of synoid (capsaicinoid) is 250 mg% to 350 mg%, and it is reported that the pulp is not included in the pulp of relatively low capsaicinoid content.
  • the capsaicin is known to have a variety of effects, such as humoral immune activity and cancer gene expression control and anti-geriatric effects, functional dyspepsia, energy metabolic rate, bactericidal action.
  • red pepper is mainly used for pulp, and is removed from the manufacturing process of red pepper powder, which is the main method of using red pepper, and treated as waste. It is true. Therefore, the development of various application methods for the red pepper seed is required, but unlike the red pepper flesh of the red pepper portion, there are almost no studies on the red pepper seed including the study on the physiological activity or the active ingredient related to the physiological activity.
  • An object of the present invention is to solve the problems of the prior art as described above, an object of the present invention is to provide a composition for treating, improving or preventing metabolic diseases comprising a red pepper seed extract as an active ingredient.
  • the present invention provides a pharmaceutical composition for the treatment or prevention of metabolic diseases comprising red pepper seed extract as an active ingredient.
  • the metabolic disease treatment or prevention composition may be a pharmaceutical composition or a pharmaceutical composition.
  • composition for treating or preventing metabolic diseases may include pepper seed extract, specifically, pepper seed water extract extracted with water.
  • the metabolic disease may be obesity, diabetes or hyperlipidemia, specifically obesity or diabetes, for example obesity.
  • the present invention provides a composition for improving or preventing metabolic diseases in order to achieve the above object.
  • the metabolic disease improvement or prevention composition may be a food composition.
  • the food composition may be a functional food composition.
  • the metabolic disease improvement or prevention composition may include a pepper seed extract as an active ingredient.
  • the pepper seed extract may be a hot pepper seed hot water extract.
  • the present invention may be a food composition for improving or preventing obesity or diabetes comprising red pepper seed extract as an active ingredient.
  • the food composition may be a dietary supplement for improving or preventing obesity or diabetes.
  • Red pepper seed extract the active ingredient of the present invention, inhibited the proliferation of pro-dipotent cells into adipocytes, inhibited the increase and accumulation of adipocytes, and was found to exhibit an anti-obesity effect. Therefore, the effects of lowering insulin resistance and lowering blood cholesterol levels through the effects of weight loss and treatment, improvement or prevention of obesity are also recognized.
  • the red pepper seed extract has a significantly superior inhibitory effect on adipocyte differentiation compared to the red pepper flesh extract, but also has low cytotoxicity, and is manufactured from red pepper used for a long time for food, so no side effects, etc. Since it uses the treated part, it is recognized as an excellent industrial effect because of its economic effect.
  • the vertical axis of the graph shows the survival rate of proliferative cells (3T3-L1) relative to the control (PBS).
  • the horizontal axis of the graph represents the control group and the experimental group according to the content of the pepper seed extract, specifically, PBS is a control group without the pepper seed extract, and 10, 25, 50, 75 and 100 are 10 ⁇ g / ml, 25 of the pepper seed extract, respectively.
  • the experimental group which added ⁇ g / ml, 50 ⁇ g / ml, 75 ⁇ g / ml and 100 ⁇ g / ml was shown.
  • Figure 2 shows the effect of inhibiting the differentiation of red pepper seed extract into adipocytes
  • Figure 2a shows a photograph stained with Oil Red O dye reagent showing the effect of inhibiting the differentiation of red pepper seed extract into adipocytes.
  • PBS refers to a control group without addition of red pepper seed extract
  • red pepper seed 10 red pepper seed 25, red pepper seed 50, red pepper seed 75 and red pepper seed 100 are red pepper seed extracts, respectively, 10 ⁇ g / ml, 25 ⁇ g / ml and 50 ⁇ g / ml.
  • FIG. 2b is a graph showing the effect of inhibiting the differentiation of red pepper seed extract into adipocytes, the vertical axis of the graph means a value representing the differentiation into adipocytes relative to the control (PBS).
  • the horizontal axis of the graph shows each experimental group, and PBS means a control group without adding pepper seed extract, and pepper seeds 10, pepper seeds 25, pepper seeds 50, pepper seeds 75, and pepper seeds 100 were 10 ⁇ g / ml and 25 ⁇ g /, respectively.
  • Experimental groups treated with ml, 50 ⁇ g / ml, 75 ⁇ g / ml and 100 ⁇ g / ml are shown, and pepper powder 10, red pepper powder 25, red pepper powder 50, red pepper powder 75 and red pepper powder 100 are made of red pepper powder.
  • Experimental groups treated with 10 ⁇ g / ml, 25 ⁇ g / ml, 50 ⁇ g / ml, 75 ⁇ g / ml and 100 ⁇ g / ml, respectively, are shown.
  • FIG. 3 is a graph showing the effect of inhibiting the expression of adipocyte differentiation gene according to the content of red pepper seed extract according to an embodiment of the present invention, a picture showing the expression level of PPAR ⁇ , PBS of the horizontal axis, 10, 25, 50, 75 and 100 represent a control group treated with PBS and an experimental group to which 10 ⁇ g / ml, 25 ⁇ // ml, 50 ⁇ // ml, 75 ⁇ // ml and 100 ⁇ // ml were added, respectively.
  • Figure 4 is a graph showing the toxicity in the animal model of pepper seed extract, according to an embodiment of the present invention, the vertical axis of the graph represents the liver weight / weight, the horizontal axis is the control (control), pepper seed extract 200mg / kg And experimental groups treated with 400 mg / kg, respectively.
  • Figure 5 is a graph showing the effect on the body weight in the animal model of pepper seed extract, according to an embodiment of the present invention, the vertical axis represents the weight (g), the horizontal axis represents the number of experimental days control is a control, pepper seed ex . 200 mg / kg of pepper seed extract 200 mg / kg administration group and pepper seed ex. 400 mg / kg represents a 400 mg / kg dose group of red pepper seed extract.
  • Figure 6 is a graph showing the effect on the blood sugar, insulin and insulin resistance of the pepper seed extract, according to an embodiment of the present invention, the horizontal axis of the graph is the control (control), pepper seed extract 200mg / kg and 400 mg The experimental group treated / kg each, Figure 6a is a graph showing the effect on the blood sugar of pepper seed extract, the vertical axis represents the blood sugar concentration (m mol / L), Figure 6b is a graph showing the effect of pepper seed extract on insulin The vertical axis of the graph shows the insulin concentration ( ⁇ L U / ml), Figure 6c is a graph showing the insulin resistance of the pepper seed extract, the vertical axis represents the degree of insulin resistance.
  • Figure 7 is a graph showing the effect on the serum triglycerides and cholesterol of the red pepper seed extract, according to an embodiment of the present invention, the horizontal axis of each graph control (control), red pepper seed extract 200mg / kg and 400 mg / kg
  • Figure 7a shows the experimental group treated, respectively, the vertical axis in the graph showing the serum triglyceride reduction effect of red pepper seed extract, the vertical axis represents the concentration of serum triglyceride (mg / dl)
  • Figure 7b is the graph showing the cholesterol reduction effect of red pepper seed extract Indicates cholesterol concentration (mg / ml).
  • Figure 8 is a graph showing the effect on the free fatty acid of pepper seed extract, according to an embodiment of the present invention, the horizontal axis of the control group (control), pepper group 200mg / kg and experimental group treated 400 mg / kg, respectively
  • the vertical axis represents the concentration of free fatty acid (mM).
  • Red pepper seeds were purchased commercially to remove red pepper seeds. 100 ml of red pepper seeds was added to 900 ml of distilled water, extracted for 30 minutes, filtered, concentrated under reduced pressure in a water bath of 40 ° C. or lower, and dried again using a freeze dryer system. It is shown in Table 1 below. A sample of the powder obtained as a result of the above was obtained and used for the experiment. The yield of lyophilisate was 11.4% on average.
  • capsaicinoid which is a major bioactive substance of red pepper flesh, was not found, so it was confirmed that capsaicinoid, that is, capsaicin and its derivatives were not included. It became.
  • Preadipocytes 3T3-L1 cell line was used from the American Type Culture Collection (ATCC, USA). Preadipocytes 3T3-L1 cells were treated with 5% CO 2 under Dulbecco's Modified Eagle Medium (DMEM, Hyclone) medium containing 100 Units / mL penicillin, 100 ⁇ g / mL streptomycin and 10% newbone calf serum (FCS, Hyclone). Subcultured at 37 °C cell culture was used for the experiment.
  • DMEM Dulbecco's Modified Eagle Medium
  • FCS newbone calf serum
  • MTT assay was performed to evaluate the cytotoxicity of the red pepper seed extract on the proliferative cells. After incubating 3T3-L1 cells in a 96-well plate, red pepper seed extract was added to each of 10 ⁇ g / ml, 25 ⁇ g / ml, 50 ⁇ g / ml, 75 ⁇ g / ml and 100 ⁇ g / ml, respectively. ), Proliferative capacity of pro-adipocytes using MTT [3- (4,5-methylthiazol-2-yl) 2,5-diphenyl tetrazolium bromide] assay at 2 days (48 hours) and 3 days (72 hours), respectively. Survival rate) was measured and the results are shown in FIG. 1.
  • the progenitor cells 3T3-L1 cells passaged in Experimental Example 1-1 were dispensed on 6-well plates and cultured for 2 days. Even if the cells were completely grown in the well plate, the cells were cultured again for 2 days, and then differentiated into induction culture medium (DMEM medium containing 10 ⁇ g / ml insulin, 0.5 ⁇ M dexamethasone, and 0.8 mM isobutylmethyl xanthine) to induce differentiation for 2 days. Then, the cells were replaced with DMEM medium containing only 10 ⁇ g / ml insulin and incubated for 2 days, and then exchanged with DMEM medium containing 10% FBS for 4 days.
  • induction culture medium DMEM medium containing 10 ⁇ g / ml insulin, 0.5 ⁇ M dexamethasone, and 0.8 mM isobutylmethyl xanthine
  • the differentiation degree was tested by adding pepper seed extract with differentiation induction to the 6-well plate cultured cells.
  • the control group PBS
  • the control group PBS
  • the red pepper seed extract was found to significantly inhibit the fat production from the 50 ⁇ g / ml treated group, and when 75 ⁇ g / ml treated, the fat production was less than about 50%, specifically about 40% It was confirmed to decrease to a degree.
  • red pepper powder it was confirmed that the degree of inhibition of fat production was lower than the red pepper seed extract in the whole range, and the inhibitory effect of the production was not so great up to the amount of 75 ⁇ g / ml. It was confirmed that the fat production of about 60% compared to the control group, pepper seed, that is, pepper seed extract compared to the red pepper pulverized extract extract was found to have a significantly superior fat production inhibitory ability.
  • 3T3-L1 adipocytes cultured in Experimental Example 1-1 were divided into 1 ⁇ 10 5 cells / well, put together differentiation-inducing substance and sample red pepper seed extract, and induced cell differentiation on day 8 after inducing differentiation. Specifically, the cultured cells are washed twice with PBS solution, and then lysis buffer (PRO-PREP protein extraction solution, Intron Biotechnology, South Korea) is added and lysed at 4 ° C. for 10 minutes. The lysed cells were harvested and centrifuged at 13,000 rpm and 4 ° C. for 20 minutes to extract the supernatant and stored at -70 C. At the same time, cell proteins were extracted and subjected to immunoblot analysis.
  • lysis buffer PRO-PREP protein extraction solution, Intron Biotechnology, South Korea
  • the cells were washed once with refrigerated phosphate buffer, followed by lysis buffer (20 mM Tris, pH7.0, 5 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.2 mM PMSF, 1 ⁇ g / ⁇ L aprotinin, 20 ⁇ g). / ⁇ L leupeptin, 1 mM Na 3 VO 4 , 10mMNaF, 1mMpyrophosphate, 1mMß-glycerophosphate) was added to react for 10 minutes on ice. Cells were centrifuged at 20,000 ⁇ g and 4 ° C.
  • the pepper seed extract inhibited the expression of the lipogenesis-related transcription factor PPAR ⁇ as compared to the control group (PBS) to which nothing was added, and in particular, the expression of the transcription factor when the concentration of the pepper seed extract was increased. It was confirmed that more effectively suppressed. Therefore, from the above results, it was confirmed that the red pepper seed extract can treat, improve or prevent obesity by inhibiting the expression of genes that induce localization, inhibiting the localization of profat cells and inhibiting the fat festival.
  • mice Five-week-old male C57BL / 6Jms Slc mice were fed from a central laboratory animal (South Korea) and used for the experiment. The diet was fed to a high-fat diet containing 60% fat in pellet form based on AIN-93G (Table 2), and divided into experimental groups fed control and pepper seed extract. The red pepper seed extract dose was administered orally daily for 6 weeks, and the diet and water were supplied fresh daily.
  • the results of the experiment did not show a significant difference between the control group and the control group that did not administer the pepper seed extract. Therefore, it was confirmed that there was no toxicity until the dose of the pepper seed extract was 400 mg / kg.
  • the anti-obesity effect of red pepper seed extract was measured for the concentration.
  • visceral fat forms When accumulated in the abdomen of the body, visceral fat forms are more likely to become obese, visceral fat mass has a strong correlation with insulin resistance, and with elevated blood sugar, abnormal trilipidemia such as elevated serum triglycerides and lower HDL-cholesterol It is known to increase the risk of metabolic syndrome, and further experiments were conducted on the effect of reducing the red pepper seed insulin resistance.
  • the blood glucose of the experimental animal of Experimental Example 2-1 was measured by heart blood collection after fasting for 8 hours. Insulin was measured using a mouse insulin ELISA kit (Shibayagi) in the serum separated after the end of the experiment. In addition, in order to evaluate insulin resistance, the HOMA-IR was calculated by the following formula, and the results are shown in FIG. 6.
  • the blood glucose level of the experimental group to which the red pepper seed extract was administered was decreased compared to the control group, and as shown in FIG. 6B, the fasting insulin concentration of the experimental group to which the red pepper seed extract was administered was significantly reduced. Since the HOMA model is used to evaluate insulin sensitivity and ⁇ -cell function from fasting insulin and blood glucose, it was confirmed that the red pepper seed extract reduced fasting insulin concentration and blood glucose through the results shown in FIGS. 6A and 6B. It was confirmed that the pepper seed extract can reduce insulin resistance.
  • both the serum triglyceride and cholesterol concentration in the pepper seed extract administration group was significantly reduced compared to the control group, especially in the case of 400mg per kg body weight significantly reduced both triglyceride and cholesterol compared to the control group The effect could be observed.
  • the present invention relates to a composition for treating or preventing metabolic diseases, such as obesity.
  • the metabolic disease for example, a composition for treating or preventing obesity may be a pharmaceutical composition or a pharmaceutical composition.
  • the composition for treating or preventing obesity may include pepper seed extract, specifically, pepper seed water extract extracted with water.
  • the present invention provides a composition for improving or preventing metabolic diseases, such as obesity, in order to achieve the above object.
  • the composition for improving or preventing obesity may be a food composition.
  • the food composition may be a functional food composition.
  • the inventors of the present invention while studying the natural plant-derived ingredients effective in obesity, pepper seeds, which are mostly used as waste, unlike pepper pulp, have superior obesity treatment, improvement and prevention effect compared to chili pulp, obesity treatment and improvement Or it can be used as a preventive composition to complete the present invention.
  • an active ingredient means a component that provides an anti-obesity effect in a composition, specifically a pharmaceutical composition or a food composition.
  • the present invention relates to a composition for treating or preventing obesity, which comprises red pepper seed extract as an active ingredient.
  • the composition for treating or preventing obesity may be a pharmaceutical composition or a pharmaceutical composition.
  • the obesity refers to a state in which fat tissue is excessively accumulated due to quantitative and numerical increase of adipocytes in the body, and the quantitative increase of such fat cells is due to localization, ie, differentiation of fat cells and accumulation of fat. It means to happen.
  • the pepper seed refers to the seeds contained in the flesh of the pepper, the pepper (pepper, Capsicumannuum ) is a high-temperature crop of South America origin, mainly pulp and leaves have been used for food.
  • the main physiologically active substance of the red pepper flesh extract is capsanthin, capaorubin, vitamin, capsaicin, or organic acid, and the like.
  • capsaicin In relation to the capsaicin has been reported effects such as humoral immune hyperactivity and oncogene expression regulation, functional dyspepsia, energy metabolic rate or bactericidal action.
  • the study of the pepper has been conducted mainly to study the pepper pulp, the research on the pepper seeds is rarely progressed at home and abroad.
  • the red pepper seed extract inhibits the differentiation of pro-dipotent cells into adipocytes, inhibits the expression of transcription factors that induce differentiation into adipocytes, inhibits the accumulation of fat in the body and the increase in body weight, reduces resistance to insulin, and
  • obesity was not only treated or prevented, and the anti-obesity effect was found to be remarkably superior to the red pepper extract, and further analysis showed that the content of capsaicin was not high unlike the red pepper extract. It was confirmed that the excellent effect was derived by the ingredient different from the active ingredient exhibiting the effect of the existing pepper flesh extract or pepper extract.
  • capsicinoid which is a main active substance of the red pepper flesh extract
  • capsicinoid which is a main active substance of the red pepper flesh extract
  • liver weight / weight of the experimental animal confirmed that there is no significant change of liver weight / body weight in the experimental animal to which the pepper seed extract was administered, It was confirmed that it has an obesity effect but does not exhibit cytotoxicity. Specifically, when the toxic substance is administered to the body, the size and weight of the liver increases, and it was confirmed that the ratio of liver weight / body weight did not change in the experimental animals administered the red pepper seed extract.
  • the red pepper seed extract inhibits weight gain and body fat accumulation and inhibits blood glucose and insulin concentrations to reduce insulin resistance, thereby treating, improving or preventing metabolic syndrome caused by obesity.
  • the extract may be prepared by extracting with an extraction solvent or by adding a fractional solvent to the extract prepared by extracting with an extraction solvent.
  • the extraction solvent of the red pepper seed extract may be any one selected from the group consisting of water, an organic solvent and a combination thereof, and the organic solvent may be a polar solvent such as alcohol having 1 to 5 carbon atoms, dilute ethyl acetate or acetone, and the like.
  • the alcohol having 1 to 5 carbon atoms may be methanol, ethanol, propanol, butanol, isopropanol, and the like, but is not limited thereto.
  • the alcohol dilution water may be diluted with water to 50% (v / v) to 99.9% (v / v) alcohol.
  • Extraction solvent of the red pepper seed extract may be preferably at least one selected from the group consisting of water, alcohol having 1 to 5 carbon atoms, alcohol dilution water and mixtures thereof, more preferably water, alcohol having 1 to 4 carbon atoms and It may be any one selected from the group consisting of a mixture thereof, even more preferably may be water.
  • Extraction time of the pepper seed extract is not particularly limited, but may be extracted for 30 minutes or more, for example, may be extracted for 28 minutes to 35 minutes.
  • Extraction temperature of the red pepper seed extract may be carried out at the extraction temperature that is usually made at the time of plant extraction in the technical field to which the present invention belongs.
  • the extracting method of the red pepper seed extract may be prepared according to a conventional method of preparing a plant extract, but may be, for example, cold needle extraction method, hot needle extraction method, heat extraction method, ultrasonic extraction method, but is not limited thereto. Ultrasonic grinding extractors or fractionators may be used.
  • the fraction is an extract extracted with an extraction solvent to any one solvent selected from the group consisting of hexane, methylene chloride, acetone, ethyl acetate, ethyl ether, chloroform, water and mixtures thereof, preferably hexane, methylene chloride and ethyl acetate
  • the fractionation process may be further performed with one or more solvents selected from the group consisting of.
  • Two or more solvents may be used in the fractionation, and the fractions of each extract may be prepared using sequentially or mixed according to the polarity of the solvent.
  • the fractionation process may be performed at 4 ° C. to 120 ° C., or 50 ° C. to 90 ° C., or 60 ° C. to 80 ° C., but is not limited thereto.
  • the red pepper seed extract or the fraction obtained by performing the fractionation process may be filtered or concentrated or dried to remove the solvent, it can be carried out both filtration, concentration and drying.
  • the filtration may be performed using a filter paper or a reduced pressure filter
  • the concentration may be concentrated under reduced pressure using a reduced pressure concentrator, for example, a rotary evaporator
  • the drying may be performed by, for example, a lyophilization method.
  • the red pepper seed extract may be preferably concentrated in a vacuum and concentrated in a freeze-dried powder form to extract and filtered the red pepper seeds in the extraction container with the extraction solvent.
  • the obtained extract can be stored in a deep freezer until use.
  • Obesity treatment or prevention composition comprising the red pepper seed extract as an active ingredient, in addition to the active ingredient, nutrients, vitamins, electrolytes, flavors, coloring agents, neutralizing agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protection Sex colloid thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated drinks, and the like may further be included.
  • the carrier, excipient or diluent may be lactose, dextrose, sucrose, sorbitol, mannitol, ziitol, erythritol, maltitol, starch, acycia rubber, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, microcrystalline In the group consisting of cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, dextrin, calcium carbonate, propylene glycol, liquid paraffin, physiological saline It may be one or more selected, but is not limited to any conventional carrier, excipient or diluent can be used.
  • the ingredients may be added independently or in combination with the active ingredient, ie pepper seed extract.
  • Obesity treatment or prevention composition comprising the red pepper seed extract as an active ingredient is 0.001% to 99.9% by weight, preferably 0.1% to 99% by weight, more preferably 1% by weight of the active ingredient relative to the total weight of the composition % To 50% by weight.
  • the content of the additional component may be added in the range of 0.1% to 20% by weight based on the total weight of the composition for treating or preventing obesity, but is not limited thereto.
  • compositions for treating or preventing obesity containing the red pepper seed extract as an active ingredient can be used orally or parenterally.
  • solid preparations for oral administration include tablets, pills, powders, granules, capsules, and the like, and the solid preparations include at least one excipient such as starch, calcium carbonate ( It is prepared by mixing calcium carbonate, sucrose or lactose, gelatin and the like.
  • excipients such as starch, calcium carbonate ( It is prepared by mixing calcium carbonate, sucrose or lactose, gelatin and the like.
  • lubricants such as magnesium stearate and talc are also used.
  • Liquid preparations for oral use include suspensions, solvents, emulsions, and syrups.
  • various excipients may include, for example, wetting agents, sweeteners, fragrances, and preservatives. have.
  • the formulation of the composition for treating or preventing obesity comprising the red pepper seed extract of the present invention as an active ingredient may be in a preferred form depending on the method of use, and in particular, provides rapid, sustained or delayed release of the active ingredient after administration to a mammal. It can be formulated by adopting a method known in the art to do so. Examples of specific formulations include granules, powders, syrups, solutions, suspensions, tablets, injections, spirits, cataplasma, capsules, soft or hard gelatin capsules, and the like.
  • composition for treating or preventing obesity comprising the red pepper seed extract of the present invention as an active ingredient may be prepared using Remington's Pharmaceutical Sciences (Remington's Pharmaceutical Science, recent edition), Mack Publishing Company, Easton PA Formulated preferably using the method disclosed herein.
  • the dosage of the composition for treating or preventing obesity comprising the red pepper seed extract according to the present invention as an active ingredient may be appropriately selected by those skilled in the art in consideration of the method of administration, the age, sex and weight of the taker, and the severity of the disease. have.
  • the composition for treating or preventing obesity comprising the red pepper seed extract of the present invention as an active ingredient is 0.0001 mg / kg to 1000 mg / kg, based on the active ingredient, in order to be more effective, from 0.01 mg / kg to It may be administered at 500 mg / kg. Administration may be administered once a day or may be divided several times.
  • the dosage does not limit the scope of the invention in any aspect.
  • composition for treating or preventing obesity comprising the red pepper seed extract of the present invention as an active ingredient may further include an extract for a compound or natural product having a known obesity treatment or prophylactic effect in addition to the active ingredient, and the active ingredient 5 parts by weight to 200 parts by weight with respect to 100 parts by weight, respectively.
  • the present invention relates to a food composition for improving or preventing obesity, including red pepper seed extract as an active ingredient.
  • the food composition may be a dietary supplement composition.
  • the present invention also relates to an obesity improvement or prevention health functional food comprising the composition for improving or preventing obesity comprising the red pepper seed extract as an active ingredient.
  • the food means a natural product or processed product containing one or more nutrients, and preferably means a state in which it can be directly eaten through a certain processing process. It is intended to include all beverages, food additives and beverage additives.
  • the food includes various foods, beverages, gums, teas, vitamin complexes, and health functional foods.
  • the food in the present invention includes special nutritional products (e.g., prepared oils, infants, baby food, etc.), processed meat products, fish products, tofu, jelly, noodles (e.g. ramen, noodles, etc.), health supplements, seasoned foods ( For example, soy sauce, miso, red pepper paste, mixed soy sauce), sauces, confectionery (e.g. snacks), dairy products (e.g.
  • fermented milk, cheese, etc. other processed foods
  • kimchi, pickles various kimchi, pickles, etc.
  • beverages examples include, but are not limited to, fruits, vegetable drinks, soy milk, fermented beverages, and the like, and natural seasonings (eg, ramen soup).
  • the food, health functional food, beverages, food additives and beverage additives may be prepared by conventional manufacturing methods.
  • a health functional food is a biological defense rhythm control, disease prevention and the like having a food group or a food composition which has added value to the food by using physical, biochemical, biotechnological techniques, etc. It refers to a food that is designed and processed to fully express the weight control function related to recovery.
  • the dietary supplement may include food acceptable food additives, and may further include appropriate carriers, excipients and diluents commonly used in the manufacture of dietary supplements.
  • the drink is a generic term for drinking to quench thirst or enjoy the taste and is intended to include a health functional beverage.
  • the beverage is not particularly limited to other ingredients other than including the red pepper seed extract as an active ingredient in the indicated proportions as an active ingredient, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks. .
  • natural carbohydrates examples include monosaccharides such as glucose, fructose and other disaccharides such as maltose, sucrose and the like and polysaccharides such as dextrin, cyclodextrin and the like, and Sugar alcohols such as xylitol, sorbitol, and erythritol.
  • natural flavoring agents tauumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used.
  • the ratio of the natural carbohydrate may generally be about 1 to 20 g, preferably 5 to 12 g per 100 ml of the food composition of the present invention, in addition to the composition of the present invention for the production of natural fruit juices, fruit juice drinks, vegetable drinks It may further contain pulp for.
  • the food composition of the present invention includes various nutrients, vitamins, minerals (electrolytes), flavors such as synthetic flavors and natural flavors, coloring and neutralizing agents (such as cheese, chocolate), pectic acid and salts thereof, alginic acid and Salts, organic acids, protective colloid thickeners, pH regulators, stabilizers, preservatives, glycerin, alcohols, carbonation agents used in carbonated beverages, and the like.
  • These components can be used independently or in combination.
  • the proportion of such additives is not so critical, but may be selected from 0 to 2,000 parts by weight per 100 parts by weight of red pepper seed extract of the present invention.
  • the health functional beverage is a biological defense rhythm control, disease prevention and recovery of a beverage group or beverage composition that has added value to the beverage by using physical, biochemical, biotechnological techniques, etc. It refers to a beverage that is designed and processed to fully express the gymnastics function in relation to the living body.
  • the health functional beverage is not particularly limited to other ingredients other than the red pepper seed extract of the present invention as an essential ingredient in the indicated ratio, and may contain various flavors or natural carbohydrates as additional ingredients, such as ordinary drinks.
  • natural carbohydrates examples include monosaccharides such as glucose, fructose and other disaccharides such as maltose, sucrose and the like and polysaccharides such as dextrin, cyclodextrin and the like, and xylitol Sugar alcohols such as sorbitol and erythritol.
  • natural flavoring agents tacumatin, stevia extract (for example, rebaudioside A, glycyrrhizin, etc.) and synthetic flavoring agents (saccharin, aspartame, etc.) can be advantageously used.
  • the proportion of said natural carbohydrates is generally about 1 g to 20 g, preferably 5 g to 12 g per 100 ml of the composition of the present invention.
  • the active ingredient may be included in 0.01 to 15% by weight of the total food weight
  • the beverage composition is 0.02 g based on 100 ml To 5 g, preferably 0.3 g to 1 g.
  • the red pepper seed extract of the present invention has been confirmed that the anti-obesity effect, in particular, the anti-obesity effect, specifically, inhibiting the effect of adipocyte differentiation and adipocyte size increase compared with the red pepper flesh extract, effective red pepper seed extract of the present invention It was confirmed that the food composition containing as an ingredient shows the outstanding obesity prevention or improvement effect.
  • Red pepper seed extract as an active ingredient of the present invention is not only anti-obesity effect, insulin resistance reduction effect, blood cholesterol reduction effect is recognized, but also low cytotoxicity, since it is prepared from pepper used for a long time for food, so no side effects, etc. It can be widely used in industries related to the treatment, amelioration or prevention of various metabolic diseases, including obesity, obesity and diabetes.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

La présente invention concerne une composition pour traiter ou prévenir l'obésité, contenant un extrait de graines de piment comme ingrédient actif. En particulier, l'extrait de graines de piment, qui est l'ingrédient actif de la présente invention, peut inhiber la différentiation d'un préadipocyte en un adipocyte, peut inhiber une augmentation de poids et de graisse corporelle en inhibant une accumulation des adipocytes, inhibe les taux de sucre sanguin et d'insuline, et réduit les taux de graisse neutre et de cholestérol, en traitant et en prévenant de cette façon l'obésité, et n'a pas de cytotoxicité. De plus, il n'y a pas d'effet secondaire puisque l'ingrédient actif est une substance naturelle. En particulier, les effets de l'extrait de graines de piment sont de loin supérieurs par comparaison à un extrait de piment frais, et donc peut être largement utilisé pour traiter ou prévenir l'obésité.
PCT/KR2013/008809 2013-04-03 2013-10-02 Composition pour traiter ou prévenir l'obésité, contenant de l'extrait de graines de piment Ceased WO2014163262A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20130036231 2013-04-03
KR10-2013-0036231 2013-04-03

Publications (1)

Publication Number Publication Date
WO2014163262A1 true WO2014163262A1 (fr) 2014-10-09

Family

ID=51658526

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/008809 Ceased WO2014163262A1 (fr) 2013-04-03 2013-10-02 Composition pour traiter ou prévenir l'obésité, contenant de l'extrait de graines de piment

Country Status (1)

Country Link
WO (1) WO2014163262A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121253525A (zh) * 2025-12-04 2026-01-02 四川省农业科学院园艺研究所 一种基于特异薄壁细胞厚度的辣椒辣度快速检测方法及应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010074574A (ko) * 2001-05-08 2001-08-04 이대열 다슬기(알갱이)와 고추씨를 혼합한 면의 특징 및 그제조방법
KR20080002384U (ko) * 2006-12-29 2008-07-03 유현덕 고추씨 추출액을 함유한 매운맛 단무지

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010074574A (ko) * 2001-05-08 2001-08-04 이대열 다슬기(알갱이)와 고추씨를 혼합한 면의 특징 및 그제조방법
KR20080002384U (ko) * 2006-12-29 2008-07-03 유현덕 고추씨 추출액을 함유한 매운맛 단무지

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KIM, YU-NA ET AL.: "Effects of Water Extracts of Red Pepper Seeds Powder on Antioxidative Enzyme Activities and Oxidative Damage in Rats Fed High-Fat and High- Cholesterol Diets", THE JOURNAL OF KOREAN NUTRITION SOCIETY, vol. 44, no. 4, 2011, pages 284 - 291 *
SONG, W.-Y. ET AL.: "Effect of red pepper seeds powder on lipid composition in rats fed high-fat high-cholesterol diets", JOURNAL OF FOOD SCIENCE AND NUTRITION, vol. 15, 2010, pages 184 - 188 *
SONG, W.-Y. ET AL.: "Effects of ethanol extracts from red pepper (Capsicum annuum L.) seeds on cholesterol adsorption capacity and UDP-glucuronyl transferase activity", JOURNAL OF LIFE SCIENCE, vol. 21, no. 6, 2011, pages 829 - 837 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN121253525A (zh) * 2025-12-04 2026-01-02 四川省农业科学院园艺研究所 一种基于特异薄壁细胞厚度的辣椒辣度快速检测方法及应用

Similar Documents

Publication Publication Date Title
KR20120002131A (ko) 울금 추출물을 함유하는 비만 치료 또는 예방용 조성물
WO2014058142A1 (fr) Composition pharmaceutique contenant un extrait d'aster glehni en tant que principe actif pour la prévention et le traitement de l'obésité et de troubles métaboliques
KR101785495B1 (ko) 감국 추출물 또는 분획물을 유효성분으로 포함하는 비만, 비만 관련 질환 또는 합병증의 예방, 개선 또는 치료용 조성물
WO2020091265A1 (fr) Composition comprenant un extrait de sureau comme composant actif pour prévenir ou traiter le syndrome climatérique masculin ou réduire ses symptômes
JP7303582B2 (ja) インディアングーズベリー抽出物と大麦若葉抽出物との複合物（ｉｂ複合物）を有効成分として含む肥満及び／または糖尿を伴うメタボリックシンドロームの予防、改善治療用組成物
KR101445966B1 (ko) 백두구 추출물을 포함하는 항비만 조성물
KR101497109B1 (ko) Ｐｐａｒ 작용 조절 질환의 예방, 개선 또는 치료용 조성물
KR20160123130A (ko) 감국 추출물 또는 분획물을 유효성분으로 포함하는 비만, 비만 관련 질환 또는 합병증의 예방, 개선 또는 치료용 조성물
KR101954890B1 (ko) 해마 추출물을 포함하는 비알코올성 지방간 치료 또는 개선용 조성물
KR102698536B1 (ko) 생열귀나무 추출물을 유효성분으로 포함하는 항비만용 조성물
WO2015167240A1 (fr) Composition contenant un extrait de scutellaria alpina
WO2014163262A1 (fr) Composition pour traiter ou prévenir l'obésité, contenant de l'extrait de graines de piment
KR101851639B1 (ko) 모과 추출물 또는 이의 분획물을 유효성분으로 함유하는 항비만용 조성물
KR102515226B1 (ko) 풋귤 및 검정무의 혼합발효물을 포함하는 약학 조성물
KR20150012926A (ko) 구절초 추출물을 포함하는 항비만 조성물
KR20230048238A (ko) 캐롭 추출물을 포함하는 대사증후군의 예방, 개선 또는 치료용 조성물
KR101662887B1 (ko) 다래순 추출물을 유효성분으로 포함하는 비알콜성 지방간의 예방 또는 치료용 조성물
KR101293835B1 (ko) 황기 및 차전초의 복합 추출물을 유효성분으로 함유하는 비만증의 예방 및 치료용 조성물.
KR101257329B1 (ko) 해삼 추출물을 함유하는 비만 치료 또는 예방용 조성물
KR102849878B1 (ko) 유색미 추출물을 유효성분으로 포함하는 비만의 예방, 개선 또는 치료용 조성물
KR102606384B1 (ko) 팥순 유래 화합물을 포함하는 비만 억제용 조성물
US11864575B2 (en) Composition comprising low temperature water extract of hibiscus manihot for anti-obesity
KR20140145666A (ko) 갈조소, 유근피 및 저분자 알긴산의 천연 복합물을 유효성분으로 포함하는 비만의 예방 또는 치료용 조성물
KR20190103665A (ko) 삼백초 추출물을 포함하는 비만 개선 또는 예방용 식품 조성물
KR102281039B1 (ko) 맨드라미 추출물을 유효성분으로 포함하는 비만 또는 비만으로부터 유도된 대사증후군의 개선 또는 치료용 약학적 조성물

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13880774

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13880774

Country of ref document: EP

Kind code of ref document: A1